SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LIPO-Liposome
LIPO 0.411+17.4%Nov 10 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ming Wu who wrote ()9/18/1999 10:59:00 PM
From: Donald Gravenor  Read Replies (1) of 900
 
I was thinking of buying at the $15 range in May, but missed the boat. I posted a letter questionning whether Evista would be equivalent or better than Caelix/Doxil, another liposomally encapsulated adriamycin.
It looks like I was lucky, and that we'll probably never find out the answer to the second question.
Incidently, is the Liposome company a one drug firm, or do they have a stable of other drugs under development ?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News